Patents by Inventor Nancy Boman

Nancy Boman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230270700
    Abstract: Described herein are methods for the treatment of an ophthalmic disease or disorder comprising the administration of non-retinoid visual cycle modulators.
    Type: Application
    Filed: September 23, 2022
    Publication date: August 31, 2023
    Inventors: Ryo KUBOTA, Nancy BOMAN, Claes BAVIK, Ian L. SCOTT
  • Publication number: 20200188336
    Abstract: Described herein are methods for the treatment of an ophthalmic disease or disorder comprising the administration of non-retinoid visual cycle modulators.
    Type: Application
    Filed: October 25, 2019
    Publication date: June 18, 2020
    Inventors: Ryo KUBOTA, Nancy BOMAN, Claes BAVIK, Ian L. SCOTT
  • Patent number: 10471027
    Abstract: Described herein are methods for the treatment of an ophthalmic disease or disorder comprising the administration of non-retinoid visual cycle modulators. Ophthalmic diseases and disorders which can be treated according to the methods provided herein include age-related macular degeneration (AMD), Stargardt's disease, glaucoma, and other disorders that adversely affect the retina.
    Type: Grant
    Filed: July 2, 2010
    Date of Patent: November 12, 2019
    Assignee: ACUCELA, INC.
    Inventors: Ryo Kubota, Nancy Boman, Claes Bavik, Ian L. Scott
  • Publication number: 20110003895
    Abstract: Described herein are methods for the treatment of an ophthalmic disease or disorder comprising the administration of non-retinoid visual cycle modulators.
    Type: Application
    Filed: July 2, 2010
    Publication date: January 6, 2011
    Applicant: ACUCELA, INC.
    Inventors: Ryo Kubota, Nancy Boman, Claes Bavik, Ian L. Scott
  • Patent number: 5837282
    Abstract: Novel methods are provided for loading a weakly basic drug into liposomes utilizing an electoneutral transport system. In these methods, ionophores are utilized with liposomes having a metal ion gradient to facilitate the exchange of metal ions for protons. The transported metal ion will, in some embodiments, be complexed with a chelating agent which is present in the external media.
    Type: Grant
    Filed: October 30, 1996
    Date of Patent: November 17, 1998
    Assignee: University of British Columbia
    Inventors: David B. Fenske, Pieter R. Cullis, Kim Wong, Maurer Norbert, Johanna M. Leenhouts, Elisabeth Maurer, Nancy Boman